Annual EPS
-$380.00
+$3140.00+89.20%
December 31, 2023
Summary
- As of February 12, 2025, SBFM annual earnings per share is -$380.00, with the most recent change of +$3140.00 (+89.20%) on December 31, 2023.
- During the last 3 years, SBFM annual EPS has risen by +$2834.89 (+88.18%).
- SBFM annual EPS is now at all-time high.
Performance
SBFM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.94
-$0.84-845.67%
September 30, 2024
Summary
- As of February 12, 2025, SBFM quarterly earnings per share is -$0.94, with the most recent change of -$0.84 (-845.67%) on September 30, 2024.
- Over the past year, SBFM quarterly EPS has increased by +$49.78 (+98.15%).
- SBFM quarterly EPS is now -100.18% below its all-time high of $515.15, reached on December 1, 2021.
Performance
SBFM Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$155.33
+$49.78+24.27%
September 30, 2024
Summary
- As of February 12, 2025, SBFM TTM earnings per share is -$155.33, with the most recent change of +$49.78 (+24.27%) on September 30, 2024.
- Over the past year, SBFM TTM EPS has increased by +$3050.70 (+95.16%).
- SBFM TTM EPS is now at all-time high.
Performance
SBFM TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
SBFM EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +89.2% | +98.2% | +95.2% |
| 3 y3 years | +88.2% | -32.1% | +95.3% |
| 5 y5 years | +99.8% | -32.1% | +95.3% |
SBFM EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.0% | -100.2% | +100.0% | at high | +98.5% |
| 5 y | 5-year | at high | +98.0% | -100.2% | +100.0% | at high | +99.8% |
| alltime | all time | at high | +100.0% | -100.2% | +100.0% | at high | +100.0% |
Sunshine Biopharma EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.94(+845.7%) | -$155.33(-24.3%) |
| Jun 2024 | - | -$0.10(-99.8%) | -$205.11(-0.3%) |
| Mar 2024 | - | -$40.00(-65.0%) | -$205.72(-35.8%) |
| Dec 2023 | -$380.00(-89.2%) | -$114.29(+125.3%) | -$320.32(-90.0%) |
| Sep 2023 | - | -$50.72(+7026.6%) | -$3206.03(-3.3%) |
| Jun 2023 | - | -$0.71(-99.5%) | -$3315.31(-1.8%) |
| Mar 2023 | - | -$154.60(-94.8%) | -$3374.60(-8.5%) |
| Dec 2022 | -$3520.00(-63.0%) | -$3000.00(+1775.0%) | -$3688.98(+2022.1%) |
| Sep 2022 | - | -$160.00(+166.7%) | -$173.83(-94.6%) |
| Jun 2022 | - | -$60.00(-87.2%) | -$3193.83(-42.5%) |
| Mar 2022 | - | -$468.98(-191.0%) | -$5553.83(-48.2%) |
| Dec 2021 | -$9520.00(+196.1%) | - | - |
| Dec 2021 | - | $515.15(-116.2%) | -$10.72 K(-14.1%) |
| Sep 2021 | - | -$3180.00(+31.4%) | -$12.49 K(+22.1%) |
| Jun 2021 | - | -$2420.00(-57.1%) | -$10.23 K(+11.7%) |
| Mar 2021 | - | -$5640.00(+350.7%) | -$9155.85(+120.7%) |
| Dec 2020 | -$3214.89(-83.0%) | -$1251.49(+36.3%) | -$4148.46(-44.0%) |
| Sep 2020 | - | -$918.00(-31.8%) | -$7403.99(-52.8%) |
| Jun 2020 | - | -$1346.36(+112.8%) | -$15.70 K(-77.3%) |
| Mar 2020 | - | -$632.61(-86.0%) | -$69.04 K(-20.5%) |
| Dec 2019 | -$18.87 K(-91.2%) | -$4507.02(-51.1%) | -$86.82 K(-25.3%) |
| Sep 2019 | - | -$9216.87(-83.1%) | -$116.18 K(-44.1%) |
| Jun 2019 | - | -$54.68 K(+197.0%) | -$207.80 K(-20.2%) |
| Mar 2019 | - | -$18.41 K(-45.6%) | -$260.50 K(-11.8%) |
| Dec 2018 | -$215.62 K(+3.6%) | -$33.87 K(-66.4%) | -$295.22 K(-2.8%) |
| Sep 2018 | - | -$100.84 K(-6.1%) | -$303.65 K(+30.7%) |
| Jun 2018 | - | -$107.38 K(+102.1%) | -$232.33 K(+4.6%) |
| Mar 2018 | - | -$53.13 K(+25.6%) | -$222.03 K(+6.7%) |
| Dec 2017 | -$208.05 K(-76.2%) | -$42.30 K(+43.3%) | -$208.05 K(-53.4%) |
| Sep 2017 | - | -$29.52 K(-69.6%) | -$446.87 K(-52.8%) |
| Jun 2017 | - | -$97.09 K(+148.1%) | -$945.88 K(-28.9%) |
| Mar 2017 | - | -$39.14 K(-86.1%) | -$1.33 M(-16.7%) |
| Dec 2016 | -$874.17 K | -$281.12 K(-46.8%) | -$1.60 M(-18.7%) |
| Sep 2016 | - | -$528.54 K(+9.8%) | -$1.96 M(+19.9%) |
| Jun 2016 | - | -$481.31 K(+57.7%) | -$1.64 M(+37.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$305.29 K(-52.9%) | -$1.19 M(+30.9%) |
| Dec 2015 | -$1.65 M(>+9900.0%) | -$647.68 K(+219.3%) | -$909.53 K(+204.3%) |
| Sep 2015 | - | -$202.81 K(+487.9%) | -$298.93 K(+127.8%) |
| Jun 2015 | - | -$34.50 K(+40.6%) | -$131.22 K(-31.8%) |
| Mar 2015 | - | -$24.53 K(-33.8%) | -$192.41 K(-19.7%) |
| Dec 2014 | - | -$37.08 K(+5.6%) | -$239.48 K(-20.3%) |
| Sep 2014 | - | -$35.11 K(-63.3%) | -$300.37 K(+3.3%) |
| Jun 2014 | - | -$95.69 K(+33.6%) | -$290.70 K(+34.0%) |
| Mar 2014 | - | -$71.61 K(-26.9%) | -$216.87 K(-39.1%) |
| Dec 2013 | - | -$97.97 K(+285.1%) | -$356.28 K(+23.0%) |
| Sep 2013 | - | -$25.44 K(+16.4%) | -$289.77 K(-11.4%) |
| Jun 2013 | - | -$21.85 K(-89.6%) | -$327.13 K(+1.4%) |
| Mar 2013 | - | -$211.02 K(+570.8%) | -$322.46 K(+173.3%) |
| Dec 2012 | - | -$31.46 K(-49.9%) | -$117.99 K(-20.6%) |
| Sep 2012 | - | -$62.80 K(+265.6%) | -$148.54 K(+19.3%) |
| Jun 2012 | - | -$17.18 K(+162.0%) | -$124.56 K(+10.3%) |
| Mar 2012 | - | -$6556.83(-89.4%) | -$112.88 K(-8.0%) |
| Dec 2011 | - | -$62.01 K(+59.8%) | -$122.72 K(-34.1%) |
| Sep 2011 | - | -$38.81 K(+606.1%) | -$186.36 K(-7.3%) |
| Jun 2011 | - | -$5496.67(-66.5%) | -$201.03 K(-72.3%) |
| Mar 2011 | - | -$16.41 K(-86.9%) | -$724.89 K(-1.6%) |
| Dec 2010 | - | -$125.65 K(+135.0%) | -$736.70 K(+20.6%) |
| Sep 2010 | - | -$53.48 K(-89.9%) | -$611.05 K(-34.7%) |
| Jun 2010 | - | -$529.35 K(+1776.1%) | -$935.28 K(+125.5%) |
| Mar 2010 | - | -$28.22 K(-92.5%) | -$414.69 K(+4.7%) |
| Oct 2009 | - | -$377.71 K(+4208.8%) | -$396.15 K(+1483.6%) |
| Jul 2009 | - | -$8766.00(+49.1%) | -$25.02 K(+14.3%) |
| Apr 2009 | - | -$5879.00(+55.0%) | -$21.88 K(-28.1%) |
| Jan 2009 | - | -$3793.00(-42.3%) | -$30.42 K(+5.3%) |
| Oct 2008 | - | -$6578.00(+16.8%) | -$28.89 K(-7.1%) |
| Jul 2008 | - | -$5631.00(-61.0%) | -$31.10 K(+22.1%) |
| Apr 2008 | - | -$14.42 K(+536.6%) | -$25.47 K(+130.5%) |
| Jan 2008 | - | -$2265.00(-74.2%) | -$11.05 K(+25.8%) |
| Oct 2007 | - | -$8788.00 | -$8788.00 |
| Jul 2007 | -$13.12 K | - | - |
FAQ
- What is Sunshine Biopharma annual earnings per share?
- What is the all time high annual EPS for Sunshine Biopharma?
- What is Sunshine Biopharma annual EPS year-on-year change?
- What is Sunshine Biopharma quarterly earnings per share?
- What is the all time high quarterly EPS for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly EPS year-on-year change?
- What is Sunshine Biopharma TTM earnings per share?
- What is the all time high TTM EPS for Sunshine Biopharma?
- What is Sunshine Biopharma TTM EPS year-on-year change?
What is Sunshine Biopharma annual earnings per share?
The current annual EPS of SBFM is -$380.00
What is the all time high annual EPS for Sunshine Biopharma?
Sunshine Biopharma all-time high annual earnings per share is -$380.00
What is Sunshine Biopharma annual EPS year-on-year change?
Over the past year, SBFM annual earnings per share has changed by +$3140.00 (+89.20%)
What is Sunshine Biopharma quarterly earnings per share?
The current quarterly EPS of SBFM is -$0.94
What is the all time high quarterly EPS for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly earnings per share is $515.15
What is Sunshine Biopharma quarterly EPS year-on-year change?
Over the past year, SBFM quarterly earnings per share has changed by +$49.78 (+98.15%)
What is Sunshine Biopharma TTM earnings per share?
The current TTM EPS of SBFM is -$155.33
What is the all time high TTM EPS for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM earnings per share is -$155.33
What is Sunshine Biopharma TTM EPS year-on-year change?
Over the past year, SBFM TTM earnings per share has changed by +$3050.70 (+95.16%)